Four decades into the HIV epidemic, the world is still struggling to keep the disease under control. While countries in the Global North have benefitted from access to life-saving drugs, those in the Global South have had to contend with exorbitant prices, barriers to access, and little help from pharmaceutical[Read More…]
The McGill Tribune
Published by the SPT, a student society of McGill University
